Medical technology firm Olympus has launched a new imaging platform in the U.S. for ear, nose, and throat (ENT) and urology applications.
The Visera S OTV-S500 imaging platform, designed for both office and outpatient settings, includes a built-in light system that can be switched between white light, stroboscopy mode (available via upgrade), and Olympus’ Narrow Band Imaging (NBI) technology, allowing for enhanced visualization to detect, characterize, and treat ENT diseases such as vocal fold polyps and glottic cancer as well as urological diseases such as nonmuscle invasive bladder cancer (NMIBC).
Olympus said that its NBI technology has been shown to reduce the likelihood of NMIBC recurrence over 12 to 35 months by 37%. However, the firm cautioned that NBI is not intended to replace histopathological sampling as a diagnostic.
The Visera S system has broad compatibility with flexible and rigid endoscopes, including diagnostic and therapeutic video rhinolaryngoscopes. Additionally, it is also compatible with HD camera heads, flexible ureteroscopes, and HD flexible cysto-nephro videoscopes, such as the CYF-VH.
The system was designed with a prefreeze function to allow it to capture clear images, and it can record video. Olympus noted that it integrates with Olympus’ nCare medical recorder and VaultStream medical content management system platform, enabling providers to capture recordings and generate a procedural record that can be accessed and shared across different locations within a medical facility.
The firm noted that the Visera S platform is not indicated for cardiac applications.